Quantitative Determination of Factors Contributing to Doxorubicin Resistance in Multidrug-Resistant Cells
- 20 December 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 81 (24), 1887-1892
- https://doi.org/10.1093/jnci/81.24.1887
Abstract
There is a large discrepancy between the changes in drug accumulation and the changes in drug cytotoxicity that accompany development of anthracycline resistance in multidrug-resistant cells. In our study, a quantitative relationship has been established between reversal of multidrug resistance by resistance modifiers and a concomitant decrease in intracellular levels of doxorubicin measured at equitoxic concentrations (IC50) in CHRC5 and 2780AD multidrug-resistant cells. (IC50 = concentration required for 50% growth inhibition.) We have demonstrated that resistance modifiers like verapamil and Ro 11–2933/001 act by increasing the effectiveness of intracellular doxorubicin, apparently by inducing redistribution of the drug from the cytoplasm to the nucleus of a multidrug-resistant cell, as shown by quantitative fluorescence microscopy. At complete reversal of resistance, as measured directly or inferred by extrapolation, the amount of intracellular doxorubicin at the IC50 as well as the ratio of nuclear doxorubicin to cytoplasmic doxorubicin were the same as those in sensitive cells. These results offer an explanation for the frequently observed discrepancies between drug accumulation and cytotoxicity and also show quantitatively that a decrease in drug accumulation and a change in intracellular drug distribution together are the only determinants of doxorubicin resistance in the multidrug-resistant cells studied. [J Natl Cancer Inst 81: 1887–1892, 1989]This publication has 39 references indexed in Scilit:
- ISOLATION AND PRELIMINARY CHARACTERIZATION OF AN ADRIAMYCIN-RESISTANT MURINE FIBRO-SARCOMA CELL-LINE1983
- CIRCUMVENTION OF VINCRISTINE AND ADRIAMYCIN RESISTANCE INVITRO AND INVIVO BY CALCIUM INFLUX BLOCKERS1983
- POTENTIATION OF VINCRISTINE AND ADRIAMYCIN EFFECTS IN HUMAN HEMATOPOIETIC TUMOR-CELL LINES BY CALCIUM-ANTAGONISTS AND CALMODULIN INHIBITORS1983
- Alterations in cell surface membranes in chinese hamster lung cells resistant to adriamycinBiochemical and Biophysical Research Communications, 1982
- ENHANCED SURVIVAL OF ADRIAMYCIN-TREATED CHINESE-HAMSTER CELLS BY 2-DEOXY-D-GLUCOSE AND 2,4-DINITROPHENOL1982
- COLLATERAL SENSITIVITY TO METHOTREXATE IN CELLS RESISTANT TO ADRIAMYCIN1979
- ACTIVE EFFLUX OF DAUNORUBICIN AND ADRIAMYCIN IN SENSITIVE AND RESISTANT SUBLINES OF P388-LEUKEMIA1979
- Mechanism of adriamycin resistance in a subline of mouse lymphoblastoma L5178Y cells.The Journal of Antibiotics, 1978
- Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemiaBiochemical Pharmacology, 1978
- UPTAKE OF ADRIAMYCIN AND DAUNOMYCIN IN L1210 AND HUMAN LEUKEMIA-CELLS - COMPARATIVE-STUDY1976